Pemetrexed maintenance therapy in advanced non-squamous NSCLC: a single institution experience

被引：0
|
作者：
Lunghi, A. [1 ]
Mazzoni, F. [1 ]
Petreni, P. [1 ]
Vannini, A. [1 ]
Brugia, M. [1 ]
Calamai, V. [1 ]
Di Costanzo, F. [1 ]
机构：
[1] Azienda Osped Univ Careggi, SC Oncol Med, Florence, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H52
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [31] Phase II study of carboplatin/pemetrexed/bevacizumab followed by bev/erlotinib maintenance for non-squamous NSCLC with WT EGFR
    Watanabe, Masahiro
    Takashina, Taichi
    Asahina, Hajime
    Amano, Toraji
    Yokouchi, Hiroshi
    Takamura, Kei
    Harada, Toshiyuki
    Honjo, Osamu
    Morikawa, Naoto
    Kinoshita, Ichiro
    ANNALS OF ONCOLOGY, 2015, 26 : 91 - 92
  • [32] First Line Therapy in Non-Squamous Cell Carcinoma of the Lung 10 Years Pemetrexed: A Standard of the NSCLC-Therapy
    Vetter, Christine
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 788 - 789
  • [33] Maintenance Therapy With Pemetrexed Improves Overall Survival in Advanced NSCLC
    不详
    ONCOLOGY-NEW YORK, 2009, 23 (07): : 638 - 638
  • [34] Implementation of reflexive genomic profiling in non-squamous NSCLC: Results of single center experience
    Brown, Jacqueline T.
    Moore, Andrew R.
    Reuss, Joshua E.
    Simon, Nicholas I.
    Gentzler, Ryan D.
    Hall, Richard Delmar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] ORIENT-11: Sintilimab plus Pemetrexed plus Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC
    Zhang, L.
    Yang, Y.
    Wang, Z.
    Fang, J.
    Yu, Q.
    Han, B.
    Cang, S.
    Chen, G.
    Mei, X.
    Yang, Z.
    Ma, R.
    Bi, M.
    Ren, X.
    Zhou, J.
    Li, B.
    Xu, W.
    Ji, Y.
    Peng, B.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (10) : E41 - E41
  • [36] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [38] Molecular testing in advanced non-squamous NSCLC in a community setting
    Kim, James J.
    Leiss, Ann E.
    Calvo, Alejandro R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Maintenance pemetrexed for non-squamous non-small cell lung cancer (NSCLC): 'real life' outcomes from a UK centre
    Lim, J.
    Neocleous, M.
    Coote, J.
    Woolf, D.
    Bayman, N.
    Lee, L.
    Sheikh, H.
    Blackhall, F.
    Califano, R.
    Summers, Y.
    LUNG CANCER, 2017, 103 : S30 - S31
  • [40] Maintenance Therapy (MT) for non-squamous advanced NSCLC: a multicenter Italian survey about patients (pts)' perspectives and physicians' awareness
    Pacchiana, M. V.
    Capelletto, E.
    Rossi, A.
    Galetta, D.
    Bordi, P.
    Ceribelli, A.
    Scotti, V.
    Cortinovis, D.
    Valmadre, G.
    Martelli, O.
    Miccianza, A.
    Del Conte, A.
    Morena, R.
    Rosetti, F.
    Ostacoli, L.
    Novello, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 124 - 125
12345